
Bone Health
Latest Content
Latest Videos
More News

Bone metastases can cause pain in patients with cancer, and 2 abstracts presented at the 2019 American Society of Clinical Oncology Annual Meeting evaluated treating this pain.

Two abstracts at the 2019 American Society of Clinical Oncology Annual Meeting analyzed bone metastases in cancer.

A study has found that 28% of men and 26% of women between the ages of 35 and 50 years have osteopenia and are at risk for osteoporosis.

A study has identified links between osteoporosis and hypertension, coronary heart disease, and cerebral infarction.

New research has identified how bone cells subdue cancer cells that have reached the bone so that the cancer cells remain dormant for decades. The finding may help researchers develop new treatments to prevent or treat metastatic disease and put cancer cells to sleep permanently.

Multifraction radiotherapy is standard to treat pain in patients with bone metastases that are mostly not in their spine, but new research has shown that single-fraction stereotactic body radiotherapy had higher rates of overall pain response and better local disease control.

Damage to mitochondria, which can occur from exposure to cigarette smoke and environmental pollutants, leads to a surge in the creation of osteoclasts that break down bone.

Between 2004 and 2017, the annual number of fall-related fractures from walking leashed dogs increased from 1671 to 4396 among adults aged 65 years or older.

Bisphosphonates, which are used to treat osteoporosis and prevent fractures, are increasingly being used more effectively in a population more likely to benefit, according to results presented at ENDO 2019, the Endocrine Society’s annual meeting.

Patients with cancer who receive high doses of bisphosphonates, used to treat bone cancer, can experience jaw damage. New preclinical research published in Bone Science Direct could prevent these patients from experiencing this loss of jawbone tissue after routine oral surgery.

Despite stroke being a risk factor for osteoporosis, broken bones, and falls, the majority of stroke survivors are not screened nor treated for these conditions, according to new research.

Ultrasound can be a cost-effective alternative to dual-energy x-ray absorptiometry, which is considered the gold standard for assessing bone health but has limited use due to the the cost, size, and technical needs required to operate the machine.

The addition of denosumab to aromatase therapy results in a significant reduction in clinical fractures and yields benefits for disease-free survival in postmenopausal women with hormone receptor–positive, early-stage breast cancer.

When breast cancer spreads, it often goes to the bones, and new research has found that exposure to dim light at night may contribute to this spread. Results from the animal study were presented at ENDO 2019, the annual meeting of the Endocrine Society.

Incidence of nonvertebral fractures significantly decreased as T-scores improved during treatment with denosumab for osteoporosis.

Study data revealed that 55% of women over age 70 are at risk of fragility fractures, but 75% of these women are not treated for osteoporosis.

FDA has approved a monoclonal antibody to treat postmenopausal women who have a higher risk of bone fracture.

Older men are less likely than older women to have their bone mineral density measured and be prescribed treatment for osteoporosis.

Which risk factors of osteoporosis can be modified, and which cannot? With osteoporosis causing more than 9 million fractures globally, understanding how to prevent it can reduce this growing threat to a rapidly aging population, researchers recently reported.


A recent review of calcium supplementation suggests that the supplements should be prescribed with caution, accounting for individual risks and benefits.

A working group of osteoporosis experts established recommendations for the design and conduct of economic evaluations in osteoporosis, as well as guidance for reporting these evaluations. The group also created a set of minimum criteria for evaluations and an osteoporosis-specific checklist of items to incorporate in economic reports.

Current screening for women between ages 50 and 64 for osteoporosis needs improvement, according to a recent comparison of treatment and screening strategies from different organizations in the United States and Canada.

Can virtual reality help prevent falls in elderly patients? A small study suggests that it can.

The use of osteoporosis medication for 12 months reduced the risk of fractures and decreased medical costs in elderly female Medicare beneficiaries with osteoporosis, according to the results of a recent study.

Despite the fact that osteoporosis is a growing public health problem in the United States and worldwide, there is poor adherence to medications to treat the problem. A recent study published in Osteoporosis International identified the factors that influence patient adherence to therapy, many of which are modifiable.

A population-based study in Taiwan examined whether or not vitamin D or bisphosphonates affect the risk of atrial fibrillation (AF) in postmenopausal women with osteoporosis.

No significant differences in bone mineral density (BMD) were observed between patients with differentiated thyroid carcinoma (DTC) who received thyroid-stimulating hormone suppression (TSHS) and those who did not, according to a recent study.











